Achilles therapeutics reports fourth quarter and year-end 2021 financial results and recent business highlights

- patient data from higher dose cnet as monotherapy and cnet in combination with checkpoint inhibitor expected in 2h 2022 -
ACHL Ratings Summary
ACHL Quant Ranking